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Abstract
Background: Etoposide is a cancer drug that induces strand breaks in cellular DNA by inhibiting topoisomerase II (topoII)
religation of cleaved DNA molecules. Although DNA cleavage by topoisomerase II always produces topoisomerase II-linked
DNA double-strand breaks (DSBs), the action of etoposide also results in single-strand breaks (SSBs), since religation of the
two strands are independently inhibited by etoposide. In addition, recent studies indicate that topoisomerase II-linked DSBs
remain undetected unless topoisomerase II is removed to produce free DSBs.
Methodology/Principal Findings: To examine etoposide-induced DNA damage in more detail we compared the relative
amount of SSBs and DSBs, survival and H2AX phosphorylation in cells treated with etoposide or calicheamicin, a drug that
produces free DSBs and SSBs. With this combination of methods we found that only 3% of the DNA strand breaks induced
by etoposide were DSBs. By comparing the level of DSBs, H2AX phosphorylation and toxicity induced by etoposide and
calicheamicin, we found that only 10% of etoposide-induced DSBs resulted in histone H2AX phosphorylation and toxicity.
There was a close match between toxicity and histone H2AX phosphorylation for calicheamicin and etoposide suggesting
that the few etoposide-induced DSBs that activated H2AX phosphorylation were responsible for toxicity.
Conclusions/Significance: These results show that only 0.3% of all strand breaks produced by etoposide activate H2AX
phosphorylation and suggests that over 99% of the etoposide induced DNA damage does not contribute to its toxicity.
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Introduction
Cancer is often treated with agents that induce DNA double-
strand breaks (DSBs) that preferentially kill dividing cells and,
therefore, are slightly more toxic to fast-growing tumor cells. The
single-strand breaks (SSBs) that are always introduced along with
the DSBs contribute little to the toxicity [1,2]. DSBs activate
several related and partially redundant protein kinases, including
ATM, ATR and DNA-PK [3]. An early event after introduction
of DSBs, but not other types of DNA damage, is the
phosphorylation of a special form of histone 2A (H2A) denoted
H2AX [4]. H2AX differs from its homologue H2A in that it
contains a distinct C-terminal extension, with a consensus target
sequence at serine 139 for the DSB-activated kinases ATM, ATR,
and DNA-PK [4,5]. Together, these kinases are responsible for the
formation of several thousands of phosphorylated H2AX sur-
rounding the DSB [5,6,7,8]. This phosphorylation initiates the
assembly of several proteins involved in the DSB response [9] and
therefore mouse cells deleted for H2AX show several DSB-
response defects [10,11,12,13]. This, and several other lines of
evidence, indicates that H2AX phosphorylation is required for the
proper amplification of the DSB response [10]. The level of H2AX
phosphorylation correlates closely with the level of DSBs and with
the level of cell death in response to DSB-inducing agents such as
ionizing radiation [14,15,16]. One of the most important DSB-
inducing drugs in cancer treatment is etoposide. Etoposide induces
DNA breaks by inhibition of topoisomerase II (topoII) [17], an
enzyme that induces transient DSBs as part of its enzymatic
mechanism [18,19,20,21]. TopoII is a homodimer, of which each
monomer is able to cleave and religate one DNA strand [22]. The
cleavage reaction is mediated through a reactive tyrosine in the
catalytic site that becomes covalently linked by a phosphotyrosyl-
bond to the 59-phosphate of the break [23]. The coordinated
actions of each monomer result in efficient introduction of a
topoII-linked DSB. After passage of an undamaged DNA
molecule through the break, topoII religates the break and
dissociates from DNA [24]. TopoII poisons such as etoposide
specifically inhibit the religation step of the enzymatic cycle, and
thereby locks covalently linked topoII to DNA [25]. Although
topoII always induces DSBs when it cleaves DNA, etoposide is also
capable of generating SSBs [22,26,27]. It has been found that
etoposide must be bound to each monomer to prevent topoII from
religating the break which leads to formation of the DSB. If only
one monomer is bound by etoposide, the unbound topoII
monomer reseals its break, generating a topoII-linked SSB [22].
Several lines of evidence indicate that most of the topoII-linked
DSBs are repaired by religation of the breaks by the enzyme itself
once etoposide has dissociated. However, if the TopoII-linked
DSBs are encountered by an RNA or DNA polymerase, TopoII-
DNA complex will be denatured [28,29]. This likely renders
topoII unable to religate the break and transforms the transient
TopoII-linked DSBs into permanent DSBs. Detection of these
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denatured enzyme from the break. Several mechanisms have been
proposed for this process including proteasome degradation
[30,31,32] endonucleolytic processing [33] or tyrosyl-DNA
phosphodiesterase mediated cleavage of the phosphotyrosyl bond
[34,35]. How the breaks are repaired is still unclear but, Ku and
ligase IV are likely involved, since cells deficient in these functions
are very sensitive to etoposide [36,37,38].
To examine etoposide-induced DNA damage further we have
compared the effect of etoposide with that of calicheamicin
(CLM), a drug that induces free (not protein-linked) DSBs. CLM
binds to the minor groove in the DNA and induces DSBs by two
radical centers present in the molecule. Generated DSBs mostly
consist of a DNA strand ending with an abasic site and a 39-
phosphoglycolate on the other strand [39]. We have previously
shown that 30% of CLM-induced DNA damage is DSBs that
efficiently activate DNA-PK, ATM and H2AX phosphorylation
[40,41,42]. In the present study we used a combination of methods
to compare SSBs, DSBs, toxicity and H2AX phosphorylation
induced by etoposide and CLM. CLM produces free DSBs and
therefore serves as a control for the extent of processing of the
topoII-linked DSBs to free DSBs. With this combination of
methods we found that etoposide mostly induces SSBs, and that
only a subset of the DSBs activates a DNA-damage response and
cell death. These results indicate that most of the DNA damage
induced by etoposide does not contribute to its toxicity.
Results
Etoposide induces mainly single-stranded DNA breaks
To examine the relative amounts of SSBs and DSBs produced
by etoposide (Fig. 1), we measured DNA strand breaks in cells
treated with etoposide. As a control we also measured DNA strand
breaks in cells treated with CLM or ionizing radiation (IR). A
treatment time of 40 min was used in this and following
experiments to facilitate comparisons between experiments.
Measurements were done with a combination of neutral constant
field gel electrophoresis (neutral CFGE) [43,44,45] and alkaline
CFGE methods (Susanne Nystro ¨m, Louise Fornander, manuscript
in preparation), which measure DSBs and total strand breaks,
(TSBs) respectively, (TSB=SSB+DSB). This pair of methods
therefore allows us to measure both DSBs and TSBs in a cell
population. In these methods, cells are molded into agarose plugs
and subjected to electrophoresis after in-gel lysis by SDS and
proteinase K. If the cells contain DNA breaks, ds DNA fragments
smaller than 10 Mbp migrate into the agarose gel. Since most of
the chromatin proteins are removed from DNA, CFGE measures
all topoII induced DNA breaks irrespective of cellular processing
of the covalently attached topoII (Fig. 1). The fraction of the DNA
that enters the gel (FAR) is proportional to the number of DNA
strand breaks. If the electrophoresis is performed under neutral
conditions (neutral CFGE) the method measures DSBs, whereas
under alkaline conditions (alkaline CFGE), the method measures
both DSBs and SSBs (TSBs). To show that alkaline CFGE and
neutral CFGE were able to distinguish between DSBs and SSBs,
we treated cells with H2O2 that produces predominantly SSBs at
these concentrations [42]. As expected, H2O2, which induces very
few DSBs [42] produced FAR only in alkaline CFGE, whereas no
increased FAR signal was obtained in neutral CFGE (Fig. 2A). In
contrast, CLM-treated cells produced FAR under both neutral
and alkaline conditions reflecting that CLM induces both SSBs
and DSBs (Fig. 2A)
From this analysis, it was evident that etoposide predominantly
induced SSBs, since alkaline CFGE detected DNA strand breaks
at etoposide concentrations that did not result in any detectable
levels of DSBs by neutral CFGE (Fig. 2B). In CLM-treated cells,
the ratio between DSBs and SSBs was higher indicating that CLM
induced more DSBs per SSB (Fig. 2A), as expected from our
previous work. To calculate the relative amount of SSBs and DSBs
produced by etoposide and CLM, we also measured TSBs and
DSBs in cells irradiated with IR (data not shown). We then
compared the FAR values from irradiated cells with the FAR
values obtained in etoposide- or CLM-treated cells. It is known
Figure 1. Etoposide-induced DNA breaks detected by CFGE. A
homodimer of topoII binds and cleaves cellular DNA. Etoposide binds
independently to each monomer to block religation and thereby locks
the topoII-DNA complex. At low concentrations, only one of the topoII
monomers will be bound by etoposide and unable to religate the
break, resulting in a topoII-linked SSB (a). When both monomers are
occupied by etoposide, a topoII-linked DSB will be generated (b).I n
CFGE cells are lysed and proteins removed from DNA by SDS and
proteinase K, allowing detection of protein-linked SSBs and DSBs.
doi:10.1371/journal.pone.0005859.g001
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PLoS ONE | www.plosone.org 2 June 2009 | Volume 4 | Issue 6 | e5859Figure 2. Strand breaks induced by etoposide and CLM. SV40-transformed fibroblasts treated with (a) CLM (0–30 nM) or (b), etoposide (0–
450 mM) for 40 min at 37uC. The induced levels of TSBs and DSBs were measured with neutral and alkaline CFGE. As a control, we also treated cells
with the SSB-inducer H2O2 (200 mM) or DSB and SSB inducer CLM (15 nM) to demonstrate that neutral CFGE fails to detect SSBs (a, separate gel). Error
bars represent variation in two separate experiments performed on two different days.
doi:10.1371/journal.pone.0005859.g002
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[1]. By comparing the FAR values from the IR-irradiated and
etoposide-treated cells, we could calculate that 1 mM etoposide
induced TSBs to the same level as 7 Gy, and DSBs to the same
level as 5 Gy. Since 1 Gy of IR produces 40 DSBs/cell and 1040
TSBs/cell [1], this comparison shows that 1 mM of etoposide
induces 200 DSBs/cell and 7280 TSB/cell. We could therefore
calculate that 97% of all strand breaks produced by etoposide were
SSBs, and less than 3% of the strand breaks were DSBs. In CLM-
treated cells, DSBs constituted 31% and SSBs 69% of all strand
breaks, as we have previously shown [41]. In conclusion, we find
that etoposide induces 30-fold more SSBs than DSBs.
Etoposide-induced DSBs are inefficient inducers of H2AX
phosphorylation
To examine to what extent etoposide induced DSBs activate
H2AX phosphorylation, we compared the levels of DSBs,
measured by neutral CFGE, and H2AX phosphorylation in cells
treated with etoposide or CLM. Neutral CFGE measures all
topoII induced DSBs irrespective of cellular processing of the
covalently attached topoII (Fig. 1B), while H2AX phosphorylation
only reflects DSBs that are detected by cellular DNA-damage
response systems. A treatment time of 40 min was used, since this
results in a maximal induction of DSBs by both drugs. CLM
produces free DSBs and it is therefore expected that all CLM-
induced DSBs will induce H2AX phosphorylation. CLM therefore
serves as a control for the extent of processing of the topoII-linked
DSBs to free DSBs.
When we plotted DSB formation against H2AX phosphoryla-
tion, it was evident that CLM induced a 20 fold higher level of
H2AX phosphorylation compared to etoposide (Fig. 3, Supple-
mentary figures S1 and S2). For instance, when we compare levels
of DSBs induced by CLM and etoposide at similar H2AX
phosphorylation levels (38 and 37 respectively), we find that CLM
induces a FAR value of 0.02 and etoposide induces FAR value of
0.53 (Fig. 3, Supplementary figures S1 and S2). Assuming that all
CLM-induced DSBs activated H2AX phosphorylation, our data
indicates that only 1 out of 20 (5%) etoposide-induced DSBs
activate H2AX phosphorylation.
Etoposide-induced DSBs are 10-fold less toxic than CLM-
induced DSBs
We also wanted to examine the biological importance of the
strand breaks induced by etoposide. We therefore analyzed colony
survival of the cells used in figure 3. When TSBs measured by
alkaline CFGE were plotted against survival, it was evident that
CLM-induced TSBs were close to 100-fold more toxic than
etoposide-induced TSBs (Fig 4A). Part of this difference could be
due to the fact that CLM induces 10-fold more DSBs than
etoposide (31% versus 3%). However, when DSBs were plotted
against survival, the CLM-induced DSBs were still 10-fold more
toxic than the etoposide-induced DSBs (Fig. 4B). We conclude that
etoposide-induced DSBs are 10-fold less toxic than CLM-induced
DSBs.
The toxic effect of etoposide-induced DNA breaks
correlates closely to the level of H2AX phosphorylation
To further explore the difference in cell death induced by
etoposide and CLM, we plotted survival against the level of H2AX
phosphorylation, which reflects DSBs that are detected by cellular
DNA-damage response systems (Fig. 5).
The data show that the survival at any given level of H2AX
phosphorylation was similar for etoposide and CLM. This opens
the possibility that etoposide-induced cell killing is due to the few
DSBs that induce H2AX phosphorylation.
Etoposide induces DSBs and H2AX phosphorylation in a
cell cycle-independent manner
One potential difference between etoposide and CLM is that
topoII poisons could induce more DNA strand breaks during the
S-phase of the cell cycle. Topoisomerases are expected to be more
active in S-phase, where they participate in relieving torsional
stress ahead of the replication forks [18]. In addition, topoII alpha
has been shown to be expressed at higher levels in dividing cells
[19]. CLM, on the other hand, cleaves DNA by a radical-
mediated process, and is not expected to induce DSBs in a cell
cycle-dependent manner. To examine this further, we first sorted
etoposide- or CLM-treated cells in G1, S, and G2 phases using
FACS according to DNA content, and measured the level of DSBs
by neutral CFGE and H2AX phosphorylation (Fig. 6). No
apparent difference in the cell cycle distribution of DSBs or
H2AX phosphorylation was evident in etoposide- or CLM-treated
cells. It is therefore unlikely that the different toxicity elicited by
etoposide- and CLM-induced DSBs was due to differences in the
cell-cycle distribution of the breaks.
Etoposide-induced DSBs induce H2AX phosphorylation
with slow kinetics
Previous reports indicate that etoposide-induced DSBs must be
denatured by RNA or DNA polymerases and the topoII moiety
must also be removed in order to induce H2AX phosphorylation
[30,31,32]. It is therefore expected that etoposide-induced DSBs
would induce H2AX phosphorylation with a delay compared with
CLM-induced DSBs.
Figure 3. Induction of H2AX phosphorylation by etoposide- or
CLM-induced DSBs. SV40-transformed fibroblasts were treated with
0–150 mM etoposide or 0–5 nM CLM before analysis of H2AX
phosphorylation and DSB-level by neutral CFGE. Error bars represent
variation in two separate experiments performed on different days.
doi:10.1371/journal.pone.0005859.g003
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CLM for different times and measured the accumulation of DSBs
via neutral CFGE and H2AX phosphorylation (Fig. 7). In CLM-
treated cells, DSBs reached a maximum after 20 min, resulting in
maximal H2AX phosphorylation after 40 min (Fig. 7A). In
etoposide-treated cells, the DSB induction was maximal after
40 min, but H2AX phosphorylation continued to accumulate and
reached its maximum only after 160 min (Fig. 7B). This indicates
that etoposide-induced DSBs require additional processing to
induce H2AX phosphorylation. These data also show that after 40
min etoposide exposure, H2AX phosphorylation is close to 50% of
its maximal value. Since we used a 40 min incubation for the
experiments shown in figure 3, these data indicate that even after
extended etoposide exposure, no more than 10% of all topoII-
linked DSBs are converted to free DSBs that can activate H2AX
phosphorylation.
Discussion
Here we have compared DNA strand breaks induced by
etoposide with the free strand breaks induced by CLM. We used a
combination of methods to measure DSBs, SSBs, toxicity and
H2AX phosphorylation to examine the relative amounts of strand-
breaks, DNA damage signaling and cell survival. We found that
only 3% of all DNA strand breaks induced by etoposide are DSBs.
Previous reports have also indicated that etoposide mostly induces
SSBs [26,27], although, to the best of our knowledge, this is the
first time that the relative amounts of SSBs and DSBs have been
measured. It is therefore necessary to modify the prevailing
paradigm that etoposide is a specific DSB-inducing agent. We
found that etoposide-induced strand breaks were 100-fold less
toxic than CLM-induced strand breaks. This 100-fold difference
could be explained by a combination of the 10-fold lower DSB
fraction induced by etoposide (34% for CLM versus 3% DSBs for
etoposide) and the 10-fold lower levels of H2AX phosphorylation
produced by etoposide induced DSBs. We also found that at the
same level of DSBs, etoposide was 10-fold less toxic than CLM
and produced 20-fold lower levels of H2AX phosphorylation. Our
data indicate that a small fraction of all etoposide-induced DSBs
activate H2AX phosphorylation, suggesting that only DSBs have
been processed to free DSBs activate the cellular DNA-damage
response system. By comparing the level of DSBs and H2AX
phosphorylation in CLM- or etoposide-treated cells, we calculated
that only 5% of all etoposide-induced DSBs induced H2AX
phosphorylation during the 40-min exposure in this experiment.
Our data also show that H2AX phosphorylation reaches 50% of
its maximal level after 40 min. Therefore, even after extended
exposure to etoposide at most 10% of the topoII-linked DSBs are
Figure 4. Effect on cell survival of etoposide- and CLM-induced
DSBs and TSBs. SV40-transformed fibroblasts were treated with 0–
150 mM etoposide or 0–5 nM CLM for 40 minutes at 37uC before
analysis of colony survival and levels of (a) TSBs or (b) DSBs by neutral
and alkaline CFGEs calculated as described in materials and methods.
Error bars represent variation in two separate experiments performed
on two different days.
doi:10.1371/journal.pone.0005859.g004
Figure 5. Cell survival and H2AX phosphorylation in response
to etoposide or CLM. SV40-transformed fibroblasts were treated with
0–150 mM etoposide or 0–5 nM CLM before analysis of colony survival
and H2AX phosphorylation. Error bars represent variation in two
separate experiments performed on two different days.
doi:10.1371/journal.pone.0005859.g005
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PLoS ONE | www.plosone.org 5 June 2009 | Volume 4 | Issue 6 | e5859Figure 6. Induction of DSBs and H2AX phosphorylation at different cell-cycle stages. G361 cells were treated with 3 or 10 nM CLM (a) or
75 mMo r2 5 0mM Etoposide (b) for 40 minutes before DNA staining, FACS sorting of G1, S and G2 cells, and analysis of DSBs by neutral CFGE. G361 cells
were untreated or treated with 0.1 nM CLM or 75 mM Etoposide (c) for 40 minutes before DNAstaining andanalysis of H2AX phosphorylation andDNA-
content to examine H2AX phosphorylation in G1, S and G2 cells. G361 cells were treated with CLM (d) or Etoposide (e) for 40 minutes before DNA
staining and analysis of H2AX phosphorylation. Error bars represent variation from two separate experiments performed on two different days.
doi:10.1371/journal.pone.0005859.g006
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etoposide-induced DNA breaks could not be attributed to
preferential induction of DNA damage at different cell-cycle
stages, since the distribution of H2AX phosphorylation was not
cell-cycle dependent, in agreement with previous results [16,46].
We also used neutral CFGE on FACS sorted cells to show that
etoposide induces DSBs in a cell cycle independent manner.
Our data indicate that possibly as much as 90% of the DSBs
produced by etoposide are held in a topoII-linked complex that is
not recognized by ATM, DNA-PK, or other DNA-damage
recognition systems. In line with this possibility, we have shown
that purified DNA-PK fails to recognize topoII-linked DSBs [47].
A previous report shows that etoposide fail to activate PARP
indicating that also the topoII-linked SSBs remain hidden from the
cellular SSB detection system [48]. It is likely that most topoII-
linked strand-breaks are simply religated by topoII when etoposide
is removed and therefore not recognized by the cell.
Previous studies show that the etoposide-induced DNA-damage
response is attenuated if cells are exposed to inhibitors of RNA and
DNA synthesis [28,29,32]. It is therefore likely that etoposide-
blocked topoII complexes become denatured and unable to
religate the break only if they are encountered by an RNA- or
DNA-polymerase (Fig. 8). Purified DNA-PK fails to recognize
denatured topoII-linked breaks, partly because its DNA-binding
subunit Ku is unable to bind [47]. The fact that proteasome
inhibitors attenuate etoposide-induced H2AX phosphorylation
indicates that removal of denatured topoII from DSBs involves
proteasome-mediated degradation of topoII at the break [32]. It is
also possible that removal of topoII occurs by other mechanisms,
for instance by a nuclease similar to Spo11-removal during meiotic
recombination [33] or by a specific cleavage of the phosphotyrosyl
bond [34,35]. Regardless of the mechanism, our data indicate that
recognition and repair of denatured topoII breaks requires
processing to produce free DSBs. Repair of these DSBs likely
occurs in a process involving Ku and Ligase IV, since mutant cells
show an extreme sensitivity to etoposide [36,37,38].
A relevant question is whether the topoII-induced SSBs
contribute to the toxicity of etoposide. Etoposide could function
similarly to camptothecin, which introduces topoisomeraseI-linked
SSBs that can be converted to DSBs during DNA synthesis via
replication fork collapse [28,49]. Several reports show that
camptothecin-induced DSBs, H2AX phosphorylation, and cell
death can be prevented if cells are prevented from entering S-
phase [49]. Our data suggest that this mechanism is likely not a
major cause of etoposide-induced toxicity since we found that the
levels of DSBs and H2AX phosphorylation were not increased in
S-phase cells. It is therefore likely that etoposide confers its toxicity
exclusively by the few free DSBs that it produces. In support of this
interpretation, we found a close correlation between cell death and
H2AX phosphorylation by etoposide and CLM. Our data
therefore support the possibility that topoII-linked DSBs that




Calicheamicin c1 (CLM) was a generous gift from George
Ellestad (Wyeth-Ayers Research). CLM was dissolved at 2 mM in
DMSO and stored at 270uC. Etoposide (Sigma) was dissolved at
170 mM in DMSO and stored at 220uC. Simian virus-40 (SV-
40)-transformed human fibroblasts (Coriell Institute for Medical
Research) were cultured in DMEM (Invitrogen) supplemented
with 10% fetal bovine serum, and penicillin/streptomycin. G361
human melanoma cells were grown in McCoys modified DMEM
(Invitrogen). Cells were grown in a humidified atmosphere with
5% CO2.
Measurement of DSBs and TSBs
DSBs were measured by neutral constant field gel electropho-
resis (neutral CFGE) [43,44,45] and quantified as described for
alkaline CFGE method. TSBs (DSBs+SSBs) were measured by
alkaline CFGE method (Susanne Nystro ¨m, Louise Fornander
manuscript in preparation). After drug exposure, the cells were
kept on ice until scraping, and all solutions added to the cells were
Figure 7. Time-dependent induction of DSBs and H2AX
phosphorylation. Analysis of DSBs and H2AX phosphorylation in
SV40-transformed fibroblasts treated with 3 nM CLM (a) or 250 mM
etoposide (b) for 0, 20, 40, 80 or 160 minutes at 37uC before analysis of
DSBs with neutral CFGE and H2AX phosphorylation. Error bars represent
variation in two separate experiments performed on two different days.
doi:10.1371/journal.pone.0005859.g007
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supplemented with 0.2 mg/ml sheared herring sperm DNA and
56 mM b-mercaptoethanol to inactivate excess CLM. The cells
were scraped from the plates, centrifuged and washed with PBS.
The washed cells were suspended in PBS and mixed with an equal
volume of melted agarose (1.25% type VII in PBS with 5 mM
EDTA) kept at 55uC and transferred to a plug mold (Biorad) and
allowed to solidify on ice for at least 10 min. The gel plugs were
then transferred to 330 ml of ice-cold deproteinization buffer
(25 mM EDTA, pH 8.5, 0.5% SDS, 3 mg/ml proteinase K added
just prior to deproteinization) and incubated at 4uC over night.
Longer incubation times increased the FAR value in untreated
cells likely because of induction of DNA strand breaks during
incubation. The plugs were then equilibrated in 1 ml of 1 mM
Tris-HCl, pH 7.5 for 1.5 h to remove SDS and proteinase K and
subsequently equilibrated in alkaline buffer (0.03 M NaOH,
2 mM EDTA, 0.5 M NaCl, 0.05% BFB) for 1.5 h. The
equilibrated gel plugs were then molded into a 0.7% agarose gel
mixed in water the day before and equilibrated in alkaline buffer
(0.03 M NaOH, 2 mM EDTA (pH 12.5)) over night at 4uC. The
assembled alkaline gel was run at 4uC for 17 h at 0.6 V/cm in
alkaline buffer (0.03 M NaOH, 2 mM EDTA (pH 12.5). The pH
in the alkaline CFGE is set to allow DNA strand-separation of the
smallest chromosomes, as this results in the highest sensitivity to
detect TSBs. Since even chromosome-sized single-stranded DNA
can migrate in agarose gels, denaturation of the smallest
chromosomes results in a background corresponding to a FAR
of 0.2 and does not reflect that untreated cells contain SSBs. The
FAR from untreated cells were therefore subtracted when the FAR
in drug treated cells were calculated. The alkaline conditions used
in the alkaline CFGE degrade all RNA, omitting the need for an
RNase step. Alkaline gel was run directly after molding of the gel
plugs. If the gel was run the next day, NaCl in the gel plugs was
lost by diffusion resulting in low FAR signal. The gels were stained
by equilibration with stain buffer (25 mM Tris-HCl pH 7.5, mg/
ml ethidium bromide) for at least 3 hours. Initially the CFGE was
done using 3H-thymidine labeled cells, allowing quantification of
the DNA by scintillation counting. We found that densitometric
analysis of the CFGE gels after staining with ethidium bromide
gave exactly the same results as quantification of the radioactivity
in the gels. We therefore used densitometric quantification of the
DNA in all subsequent experiments. The gels were scanned with a
laser scanning equipment (Typhoon 9200 Variable Mode Imager).
The relative amount of cellular DNA migrating into the gel,
fraction of activity released, FAR was quantified using Image-
Quant 5.2. Briefly, background subtracted signal in a rectangle
covering the gel plug and the DNA that migrated into the gel was
regarded as the ‘‘total DNA signal’’. The background-subtracted
signal from a smaller rectangle drawn 1 mm below the gel plug
covering the DNA that entered the gel was regarded as the
‘‘activity released’’. FAR was calculated by the following equation:
FAR=activity released/total DNA signal. Relative amounts of
DSBs and SSBs induced by etoposide were calculated by
extrapolation from the linear part of the data set and compared
to the FAR values from parallel experiments using IR. It is known
that 1 Gy of ionizing radiation induces at most 40 DSBs and 1040
TSBs per cell [1]. The FAR value from the neutral CFGE and
alkaline CFGE was used to find a drug concentration that
produced a FAR value corresponding to 1 Gy. For etoposide it
was found that 1 mM induced DSBs equal to 5 Gy and TSBs to a
level corresponding to 7 Gy of IR. Using the formula:
SSBs=TSBs2DSBs, we calculated that 1 mM of etoposide
induced 200 DSBs/cell and 7280 SSBs/cell.
Measurement of H2AX phosphorylation
H2AX phosphorylation was analyzed by (FACS) analysis as
described [50,51]. At least 100 000 cells in a 50 ml suspension
(PBS, 1 g/l BSA) were added to 150 ml Block-9 staining buffer
(PBS, 1 g/l BSA, 8% mouse serum, 0.1 g/l RNaseA, phosphatase
inhibitors (10 mM NaF, 1 mM Na2MoO4, 1 mM NaVO3),
0.25 g/l herring sperm DNA, 0.1% Triton X-100, 5 mM EDTA,
0.05% NaN3, mouse monoclonal anti-H2AXS139ph FITC
conjugate (Millipore)) and stained in dark for 3 h at 4uC. Cell
Figure 8. Etoposide-induced DNA damage in cells. A homodimer
of topoII binds and cleaves cellular DNA, generating a topoII-linked DSB.
Etoposide binds independently to each monomer to block religation,
locking the topoII monomer to the DNA break. If only one of the topoII
monomers is bound by etoposide and unable to religate the break, this
results in a topoII-linked SSB (a). When both monomers are occupied by
etoposide, a topoII-linked DSB will be stabilized (b). TopoII-linked DNA
breaks that are encountered by RNA or DNA polymerases during
etoposide exposure will be denatured and therefore unable to religate
the breaks. Denatured topoII will be cleared from the breaks, resulting
in free DSBs that can induce H2AX phosphorylation. The relative
amounts of these breaks as a percentage of all etoposide-induced
breaks are indicated.
doi:10.1371/journal.pone.0005859.g008
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cycle violet stain (Invitrogen) during the last staining hour. The
samples were then diluted with 300 ml suspension buffer (PBS,
1 g/l BSA) and analyzed. FACS analysis of cell cycle distribution
and FACS sorting of G1, S, and G2 cells based on DNA content
was done using FACSAria (B&D) with the following settings:
488 nm and 405 nm excitation lasers were used for excitation of
FITC and Vybrant Dye Cycle Violet Stain respectively. Emission
was detected with the filter/bandpass: 450/40 for FITC and 530/
30 for Vybrant Dye Cycle Violet Stain. Fluorescence intensity in
arbitrary units was plotted in histograms and the mean
fluorescence intensity was calculated using Weasel version 2.3
software
Colony survival
Cells were treated with CLM (0, 0.02, 0.06, 0.19, 0.55, 1.67 and
5 nM) or etoposide (0, 0.2, 0.6, 1.85, 5.6, 16.7, 50, 150 mM) for 40
minutes before washing and trypsinization. To allow direct
comparison of the number of strand-breaks and H2AX phos-
phorylation, cells from the same experiment (Fig. 3, 4 and 5) were
also analyzed by alkaline CFGE, neutral CFGE and H2AX
phosphorylation. For the colony assay, cells were serially diluted
and plated at different densities and grown for two weeks in
normal growth medium to allow the colonies to expand. Cells
were then fixed in methanol and stained with Giemsa before
colony counting by eye. Smaller colonies were examined in a
microscope. A colony was defined as a coherent assembly of more
than 50 cells.
Supporting Information
Figure S1 DNA strand break induction and H2AX phosphor-
ylation by calicheamicin. SV40-transformed fibroblasts were
treated with 0–5 nM CLM for 40 minutes before analysis of
H2AX phosphorylation and survival using the colony assay. Data
generated from different days are shown.
Found at: doi:10.1371/journal.pone.0005859.s001 (0.07 MB TIF)
Figure S2 DNA strand break induction and H2AX phosphor-
ylation by etoposide. SV40-transformed fibroblasts were treated
with 0–150 mM etoposide for 40 minutes before analysis of H2AX
phosphorylation and survival using the colony assay. Data
generated from different days are shown.
Found at: doi:10.1371/journal.pone.0005859.s002 (0.07 MB TIF)
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